Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corporation (ADPT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ADPT · as of Jun 8, 2026
Key Statistics
Explore Adaptive Biotechnologies Corporation Data
adpt stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 17 · Buy rate: 64.7%
The ADPT analyst consensus is Buy, based on ratings from 17 Wall Street analysts over the past 3 months. The average 12-month price target is $21.33, representing +26.21% upside from the current price of $16.90.
Competitors & Peers
adpt competitorsADPT
BEAM
CDTX
CPRX
IDYA
IRONStock Performance
Full HistoryAbout Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corporation a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and…
what is adaptive biotechnologies corporation · adpt stock overview · adaptive biotechnologies corporation company profile · who is adaptive biotechnologies corporation ceo · adpt NASDAQ · adaptive biotechnologies corporation headquarters · adaptive biotechnologies corporation business segments
About Stock Overview & Key Data
Adaptive Biotechnologies Corporation (ADPT) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 27, 2019. As of the latest trading session, ADPT stock price is $16.90, with a market capitalization of $2.7B. The stock has returned +61.72% over the past 12 months and +4.06% year-to-date.
According to 17 Wall Street analysts, the consensus rating for Adaptive Biotechnologies Corporation stock is Buy, with an average 12-month price target of $21.33. In fiscal year 2025, Adaptive Biotechnologies Corporation reported revenue of $277.0M and net income of -$59.5M. For detailed data — including Adaptive Biotechnologies Corporation revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Adaptive Biotechnologies Corporation (ADPT) stock price is $16.90. The stock is traded on NASDAQ under the ticker symbol ADPT. The 52-week range is $9.78 – $20.76.